Henry Schein, Inc.

Analysis of Henry Schein (HSIC)

Technical Analysis HSIC shows strong momentum, outperforming the market significantly over recent months despite its low beta. Trading 9% below its yearly high with a reasonable drawdown, the stock appears positioned for continued upside without being overextended. The technical picture supports a positive near-term outlook.

Fundamentals Revenue growth remains modest, but margin compression from operating expenses is a concern. While the company maintains adequate liquidity and manageable debt, profitability metrics like ROE and ROA are subdued. Operational efficiencies, particularly in inventory management, present clear areas for improvement.

Valuation Valuation metrics are mixed: while P/E ratios are stable, the extremely high PEG ratio and elevated EV/EBITDA suggest the stock is pricing in limited growth. Without peer data, it is difficult to gauge relative attractiveness, but absolute metrics indicate HSIC may be overvalued given its current earnings trajectory.

Risk HSIC’s below-market beta and lack of significant short interest point to moderate risk levels. However, investors should remain cautious of operational execution risks and potential industry headwinds that could further pressure margins.

Recommendation HSIC exhibits encouraging technical strength and manageable risk, but fundamental challenges in profitability and rich valuation metrics temper enthusiasm. Investors seeking stability in a lower-volatility name may find it acceptable, but growth-oriented investors should wait for clearer operational improvements or a more attractive entry point. Consider Hold rather than Buy at current levels.

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for Henry Schein (HSIC):

12-Month Outlook for HSIC

The primary positive catalyst for HSIC is its strong technical momentum, which could continue to drive the stock higher toward its 52-week high. However, upside potential is likely to be limited by fundamental headwinds, specifically ongoing margin compression and a valuation that appears rich relative to its modest growth trajectory. The key risk remains operational execution; failure to improve efficiency and profitability could lead to underperformance. Given the mixed signals, a target price is difficult to establish, but the stock is expected to trade in a range-bound pattern, with a likely upper bound near its yearly high and support around current levels, warranting a Hold stance.

Wall Street Consensus

Most Wall Street analysts are optimistic about Henry Schein, Inc.'s 12-month outlook, with consensus target around $82.39, indicating expected upside potential.

Overall, HSIC has investment potential but also faces challenges. Here are key factors to weigh before investing.

HSIC has demonstrated strong positive momentum with significant outperformance against the broader market over the recent period.

The stock shows robust short-term performance, gaining 8.54% over one month and 11.03% over three months while outperforming the market by 7.58% during the latter period. This substantial alpha generation, despite the stock's beta below 1.0, indicates strong relative strength and investor confidence.

Currently trading at $81.50, HSIC sits approximately 65% above its 52-week low but remains about 9% below its yearly high, suggesting room for further upside potential. The moderate distance from recent highs, combined with the manageable 17.79% maximum drawdown, indicates the stock is neither severely overbought nor oversold at current levels.

HSIC demonstrated modest revenue growth in Q4 2025, increasing 2.9% sequentially to $3.44 billion, although gross profit margin remained relatively stable at 28.9%. Net income was flat at $101 million despite the revenue increase, resulting in a slight compression of the net profit margin to 2.94%, reflecting ongoing margin pressures from operating expense growth. The operating income ratio notably declined to 5.4% from 6.2% in the prior quarter, indicating challenges in controlling SG&A expenses relative to revenue.

The company maintains moderate financial leverage with a debt-to-equity ratio of 1.14 and a manageable debt ratio of 32.9%. While the current ratio of 1.38 suggests adequate short-term liquidity, the low cash ratio of 0.05 highlights limited cash reserves relative to current liabilities. Operating cash flow to sales of 11.1% and an interest coverage ratio of 4.8x provide sufficient debt service capacity, though cash flow to debt ratio of 0.10 suggests limited flexibility for significant additional leverage.

Operational efficiency metrics show room for improvement, with return on equity at 3.1% and return on assets at 0.9%, both indicating suboptimal profitability generation from invested capital. Asset turnover of 0.31 reflects modest efficiency in utilizing the asset base to generate revenue, while inventory turnover of 1.22 and 74 days inventory outstanding suggest potential opportunities to optimize working capital management. The 44 days sales outstanding indicates reasonable receivables collection efficiency.

Valuation Level HSIC's current trailing PE of 23.28 and forward PE of 22.12 suggest a stable earnings outlook, but the extremely high PEG ratio of 9.29 indicates the market is pricing in minimal growth expectations. The elevated EV/EBITDA of 48.69 further signals the stock is richly valued relative to its core operating profitability. Based on these metrics, particularly the disconnect between the PE and PEG ratios, HSIC appears overvalued.

Peer Comparison A comprehensive peer comparison cannot be conducted as industry average data is unavailable. This lack of benchmark data prevents a clear assessment of whether HSIC's valuation multiples are in line with, or deviate significantly from, its sector peers. Therefore, the valuation conclusion is based solely on an absolute assessment of the company's own metrics.

Volatility Risk: HSIC exhibits moderate volatility with a beta of 0.893, indicating it should be slightly less volatile than the broader market. The stock's maximum drawdown of -17.79% over the past year reflects a manageable decline within typical market corrections, though it still represents a meaningful capital loss for holders over that period.

Other Risks: The notable absence of reported short interest suggests a general lack of bearish speculation against the stock, indicating market confidence or a lack of significant negative catalysts. However, investors should still monitor other fundamental risks, such as industry cyclicality and execution risks associated with the company's specific operations.